Labor Onset and Length Abnormalities clinical trials at University of California Health
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The GLEAM trial is a multicenter, pragmatic, cluster-randomized trial to assess the effects of programmed intermittent epidural bolus versus continuous epidural infusion on the rate of spontaneous vaginal delivery and several other clinically-relevant outcomes.
Our lead scientists for Labor Onset and Length Abnormalities research studies include Ronald B George, MD.